STRO
Sutro Biopharma Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$23.08
-1.37 ▼ -5.60%
🌙 3월 13일 4:42 PM ET (한국 3/14 05:42)
$23.46
+0.38 ▲ +1.65%
| Index | - | P/E | - | EPS (ttm) | -25.98 | Insider Own | 7.32% | Shs Outstand | 0.02B | Perf Week | -8.74% |
| Market Cap | 0.38B | Forward P/E | - | EPS next Y | -7.95% | Insider Trans | 10.27% | Shs Float | 0.02B | Perf Month | 46.73% |
| Enterprise Value | 0.44B | PEG | - | EPS next Q | -8.16 | Inst Own | 38.8% | Short Float | 3.41% | Perf Quarter | 156.44% |
| Income | -0.22B | P/S | 3.58 | EPS this Y | 39.84% | Inst Trans | -3.17% | Short Ratio | 3.93 | Perf Half Y | 137.94% |
| Sales | 0.11B | P/B | - | EPS next 5Y | 22.64% | ROA | -65.54% | Short Interest | 0.52M | Perf YTD | 99.48% |
| Book/sh | -10.25 | P/C | 2.26 | EPS past 3/5Y | -8.96% -4.05% | ROE | -1810.01% | 52W High | -13.04% ($26.54) | Perf Year | 84.64% |
| Cash/sh | 10.23 | P/FCF | - | Sales past 3/5Y | 0.09% 7.74% | ROIC | -163.83% | 52W Low | 341.22% ($5.23) | Perf 3Y | -57.5% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -59.98% | Gross Margin | 92.84% | Volatility(W/M) | 9.84% 10.07% | Perf 5Y | -90.14% |
| Dividend TTM | - | EV/Sales | 4.15 | Sales Y/Y TTM | -34.36% | Oper. Margin | -129.26% | ATR (14) | 1.95 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 2.53 | EPS Q/Q | -12.66% | Profit Margin | -205.18% | RSI (14) | 63.52 | Recom | 1.9 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.53 | Sales Q/Q | 13.77% | SMA20 | 10.09% ($20.96) | Beta | 1.39 | Target Price | $32.5 |
| Payout | - | Debt/Eq | - | Earnings | 11000000 | SMA50 | 37.84% ($16.74) | Rel Volume | 0.73 | Prev Close | $24.45 |
| Employees | 338 | LT Debt/Eq | - | EPS/Sales Surpr. | -69.85% -4.44% | SMA200 | 112.81% ($10.85) | Avg Volume(3M) | 0.13M | Price | $23.08 |
| IPO | 2018/9/27 | Option/Short | Yes/Yes | Trades | 2300 | Volume | 96,005 | Change | -5.6% |
뉴스 로딩 중...